DR ANTHONY MELVIN CRASTO Ph.D ( ICT, Mumbai) , INDIA 30 Yrs Exp. in the feld of Organic Chemistry. Serving chemists around the world. Helping them with websites on Chemistry.Millions of hits on google, world acclamation from industry, academia, drug authorities for websites, blogs and educational contributionn
Monday, 27 August 2012
Monday, 6 August 2012
New carbon-carbon bond in an organic reaction with the original functional groups completely disappearing
http://www.nature.com/nchem/journal/v2/n4/full/nchem.576.html
Mundal et al form a New carbon-carbon bond in an organic reaction with the original functional groups completelely dissapearing, boc protected allyl hydrazone, takes part in an triflimide catalysed sigmatropic reaction with subsequent loss of isobutylene, nitrogen gas and carbondioxide
Monday, 30 July 2012
Stereochemistry of [n,m] Sigmatropic Rearrangements
Stereochemistry of [n,m] Sigmatropic Rearrangements
Basically, [n,m] sigmatropic rearrangements can proceed through a chair or boat transition state. Only the chair transition state has been observed experimentally though both are suprafacial and are allowed in 4n+2 electron systems.
Chair and boat transition states in [n,m] sigmatropic rearrangements
Fig.1Chair
Fig.2Boat
Examples for sigmatropic rearrangements with a chair transition state
Fig.3Cope rearrangement
Fig.4[3,3] Sigmatropic
6 Electrons
Hückel aromatic
Supra-supra
view animation, 2D Animation of the Cope rearrangement
try copy paste of link below, do not miss out on a beautiful animation
http://www.chemgapedia.de/vsengine/supplement/Vlu/vsc/en/ch/2/vlu/pericyclische_reaktionen/pericyclisch_sigmatrop.vlu/Page/vsc/en/ch/2/oc/reaktionen/formale_systematik/pericyclische_reaktionen/sigmatrop/stereochemie_n_m.vscml/Fragment/0d47d3304bb08cfd9c68c1c3590965d2-19.html
Large substituents similar to their behavior in chair conformations of cyclohexane rings prefer an equatorial configuration in the transition state of [3,3] sigmatropic reactions. Heating S,S-3,4-dimethyl-1,5-hexadiene to approximately 200°C yields in 90% a product derived from a chair transition state with equatorial methyl groups. The product arising from a diaxial conformation is formed in only 10% yield. Obviously, the reaction does not proceed through the boat transition state.
Sunday, 29 July 2012
Enantiomeric Ibuprofen via Environmentally Benign Selective Crystallization
Ibuprofen
was developed by the Boots Group, a pharmacy chain in the United
Kingdom, in the 1950’s-1960s. It was discovered by Stewart Adams (along
with John Nicholson, Andrew RM Dunlop, Jeffrey Bruce Wilson & Colin
Burrows). The Boots group originally licensed Ibuprofen to two large
drug companies. The first was Whitehall Laboratories (who sold the
product as Advil) and the second was Upjohn who used Bristol-Meyers to
market their product “Nuprin”. Boots held the patent until 1985 along
with the rights to market it until 1986. Afterwards new products entered
the market creating multiple new “generic” brands.
Selective crystallization of ibuprofen/lysinate from 1 mol of (R,S)-(racemic) ibuprofen and ≤0.5 mol of (S)-lysine in aqueous ethanol affords either (S)-(+)-ibuprofen/(S)-lysinate or (R)-ibuprofen/(S)-lysinate (in preponderance) depending on the crystallization conditions. The previously unreported temperature selective diastereo-recognition (TSD) provides simple and efficient means to prepare either enantiomer of ibuprofen from (R,S)-ibuprofen utilizing the same commercially available inexpensive resolving agent, (S)-lysine. The unwanted enantiomeric ibuprofen could be recovered from the mother liquor and racemized by a simple, relatively waste-free thermal process. This racemization method when utilized in conjunction with the selective crystallization technology provides a simple, efficient, and eco-friendly means to prepare (S)-(+)-ibuprofen lysinate in an overall essentially quantitative yield. This technology also incorporates the fundamental principle of atom economy (via direct production of the preferred pharmaceutical salt of (S)-lysine).
Selective crystallization of ibuprofen/lysinate from 1 mol of (R,S)-(racemic) ibuprofen and ≤0.5 mol of (S)-lysine in aqueous ethanol affords either (S)-(+)-ibuprofen/(S)-lysinate or (R)-ibuprofen/(S)-lysinate (in preponderance) depending on the crystallization conditions. The previously unreported temperature selective diastereo-recognition (TSD) provides simple and efficient means to prepare either enantiomer of ibuprofen from (R,S)-ibuprofen utilizing the same commercially available inexpensive resolving agent, (S)-lysine. The unwanted enantiomeric ibuprofen could be recovered from the mother liquor and racemized by a simple, relatively waste-free thermal process. This racemization method when utilized in conjunction with the selective crystallization technology provides a simple, efficient, and eco-friendly means to prepare (S)-(+)-ibuprofen lysinate in an overall essentially quantitative yield. This technology also incorporates the fundamental principle of atom economy (via direct production of the preferred pharmaceutical salt of (S)-lysine).
Temperature Selective Diastereo-Recognition (TSD): Enantiomeric Ibuprofen via Environmentally Benign Selective Crystallization
see also
http://onlinelibrary.wiley.com/doi/10.1002/aic.11087/abstract;jsessionid=D60C69E3DB7266BE103A2875A7FEA6C5.d02t03?deniedAccessCustomisedMessage=&userIsAuthenticated=false
copy paste on browser
read more at
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-66322006000300003
copy paste on browser
http://onlinelibrary.wiley.com/doi/10.1002/aic.11087/abstract;jsessionid=D60C69E3DB7266BE103A2875A7FEA6C5.d02t03?deniedAccessCustomisedMessage=&userIsAuthenticated=false
copy paste on browser
read more at
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-66322006000300003
copy paste on browser
Sunday, 22 July 2012
Citalopram/Escitalopram Oxalate, Isolation & Synthesis of Novel Impurities, Emcure paper
Citalopram
Citalopram brand names: Celexa, Cipramil) is an antidepressantdrug of the selective serotonin reuptake inhibitor (SSRI) class. It has U.S. Food and Drug Administration (FDA) approval to treat major depression, and is prescribed off-label for a number of anxiety conditions.
Escitalopram (trade names Nexito, Anxiset-E (India), Lexapro,Cipralex, Seroplex, Lexamil, Lexam, Entact, Losita(Bangladesh) Reposil (Chile)), is an antidepressant of theselective serotonin reuptake inhibitor (SSRI) class. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults and children over 12 years of age with major depressive disorder and generalized anxiety disorder. Escitalopram is the (S)-stereoisomer (enantiomer) of the earlier Lundbeck drugcitalopram
Citalopram/Escitalopram Oxalate: Isolation & Synthesis of Novel Impurities
READ AT
Emcure Pharmaceuticals Ltd, R & D Centre, Pimpri, Pune -411018, India
During process optimization of Escitalopram oxalate novel impurities, 6 and 7 were observed, which were isolated and characterized, and the proposed structure was confirmed by chemical synthesis. Investigation of the cause of impurities formation improved the yield and purity of the drug product during the bulk API synthesis
SPECTROSCOPIC DATA IS AVAILABLE IN SUPPORTING INFORMATION FILE IN THE PAPER
ARTEMETHER, A FORCE AGAINST MALARIA
Artemether
is an antimalarial for the treatment of multi-drug resistant strains offalciparum malaria. It is combined with Lumefantrine and sold by Novartis under the brand names Riamet and Co-Artem.
It is a methyl ether derivative of artemisinin, which is a peroxide lactone isolated from theChinese antimalarial plant, Artemisia annua. It is also known as dihydroartemisinin methyl ether, but its correct chemical nomenclature is (+)-(3-alpha,5a-beta,6-beta,8a-beta, 9-alpha,12-beta,12aR)-decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin.
Artemether is highly effective against the blood schizonts of both malarial parasites P. falciparum and P. vivax. It is applied in combination with lumefantrine in clinical treatments of malaria.
World Health Organization guidelines for the treatment of uncomplicatedfalciparum malaria recommend the use of this artemisinin-based combination therapy, and approved by Swissmedic in December 2008 and recently approved by the United StatesFood and Drug Administration.
READ AT
http://pubs.acs.org/doi/abs/10.1021/op300037e
A 70% overall yield from the two-step conversion of naturally or synthetically derived artemisinin to pure β-artemether is obtained. This corresponds to a usage factor of 1.35 kg of artemisinin needed to produce 1 kg of β-artemether, compared to the current industry average of 1.59 kg.
Saturday, 21 July 2012
Kharasch-Sosnovsky Reaction:
Kharasch-Sosnovsky
Reaction:
copper catalysed allylic oxidation using
an organic peroxide.
In the original
publication the reactants are cyclohexene
and t-butyl perbenzoate with cuprous bromide and
the
reaction product
is cyclohex-1-en-3-yl benzoate:
Mechanism: (review: DOI). The reaction mechanism devised
by Beckwith et al (DOI) contains the
following steps:
THANKS AND REGARD'S
DR ANTHONY MELVIN CRASTO Ph.D
MOBILE-+91 9323115463
GLENMARK SCIENTIST , NAVIMUMBAI,
INDIA
web link
Subscribe to:
Posts (Atom)